These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29563325)

  • 1. Preclinical to Human Translational Pharmacology of the Novel M
    Uslaner JM; Kuduk SD; Wittmann M; Lange HS; Fox SV; Min C; Pajkovic N; Harris D; Cilissen C; Mahon C; Mostoller K; Warrington S; Beshore DC
    J Pharmacol Exp Ther; 2018 Jun; 365(3):556-566. PubMed ID: 29563325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque.
    Uslaner JM; Eddins D; Puri V; Cannon CE; Sutcliffe J; Chew CS; Pearson M; Vivian JA; Chang RK; Ray WJ; Kuduk SD; Wittmann M
    Psychopharmacology (Berl); 2013 Jan; 225(1):21-30. PubMed ID: 22825578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAK-071, a muscarinic M1 receptor positive allosteric modulator, attenuates scopolamine-induced quantitative electroencephalogram power spectral changes in cynomolgus monkeys.
    Kurimoto E; Nakashima M; Kimura H; Suzuki M
    PLoS One; 2019; 14(3):e0207969. PubMed ID: 30856192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The M1 Muscarinic Positive Allosteric Modulator PQCA Improves Performance on Translatable Tests of Memory and Attention in Rhesus Monkeys.
    Lange HS; Cannon CE; Drott JT; Kuduk SD; Uslaner JM
    J Pharmacol Exp Ther; 2015 Dec; 355(3):442-50. PubMed ID: 26446308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-495, a novel low cooperative M
    Mandai T; Sako Y; Kurimoto E; Shimizu Y; Nakamura M; Fushimi M; Maeda R; Miyamoto M; Kimura H
    Pharmacol Res Perspect; 2020 Feb; 8(1):e00560. PubMed ID: 31990455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey.
    Vardigan JD; Cannon CE; Puri V; Dancho M; Koser A; Wittmann M; Kuduk SD; Renger JJ; Uslaner JM
    Psychopharmacology (Berl); 2015 Jun; 232(11):1859-66. PubMed ID: 25491927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model.
    Puri V; Wang X; Vardigan JD; Kuduk SD; Uslaner JM
    Behav Brain Res; 2015; 287():96-9. PubMed ID: 25800972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors.
    Alt A; Pendri A; Bertekap RL; Li G; Benitex Y; Nophsker M; Rockwell KL; Burford NT; Sum CS; Chen J; Herbst JJ; Ferrante M; Hendricson A; Cvijic ME; Westphal RS; O'Connell J; Banks M; Zhang L; Gentles RG; Jenkins S; Loy J; Macor JE
    J Pharmacol Exp Ther; 2016 Feb; 356(2):293-304. PubMed ID: 26582730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive Allosteric Modulation of the Muscarinic M1 Receptor Improves Efficacy of Antipsychotics in Mouse Glutamatergic Deficit Models of Behavior.
    Choy KH; Shackleford DM; Malone DT; Mistry SN; Patil RT; Scammells PJ; Langmead CJ; Pantelis C; Sexton PM; Lane JR; Christopoulos A
    J Pharmacol Exp Ther; 2016 Nov; 359(2):354-365. PubMed ID: 27630144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse Effects on M
    Rook JM; Abe M; Cho HP; Nance KD; Luscombe VB; Adams JJ; Dickerson JW; Remke DH; Garcia-Barrantes PM; Engers DW; Engers JL; Chang S; Foster JJ; Blobaum AL; Niswender CM; Jones CK; Conn PJ; Lindsley CW
    ACS Chem Neurosci; 2017 Apr; 8(4):866-883. PubMed ID: 28001356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of the first low-shift positive allosteric modulators for the muscarinic M1 receptor.
    Flohr A; Hutter R; Mueller B; Bohnert C; Pellisson M; Schaffhauser H
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5415-5419. PubMed ID: 29146472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Approach to Discovering Novel Muscarinic M
    Kurimoto E; Matsuda S; Shimizu Y; Sako Y; Mandai T; Sugimoto T; Sakamoto H; Kimura H
    J Pharmacol Exp Ther; 2018 Jan; 364(1):28-37. PubMed ID: 29025977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M
    Hassani SA; Neumann A; Russell J; Jones CK; Womelsdorf T
    Proc Natl Acad Sci U S A; 2023 May; 120(18):e2216792120. PubMed ID: 37104474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M
    Moran SP; Dickerson JW; Cho HP; Xiang Z; Maksymetz J; Remke DH; Lv X; Doyle CA; Rajan DH; Niswender CM; Engers DW; Lindsley CW; Rook JM; Conn PJ
    Neuropsychopharmacology; 2018 Jul; 43(8):1763-1771. PubMed ID: 29581537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive effects of muscarinic M1 functional agonists in non-human primates and clinical trials.
    McArthur RA; Gray J; Schreiber R
    Curr Opin Investig Drugs; 2010 Jul; 11(7):740-60. PubMed ID: 20571970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel M(1) allosteric ligands: a patent review.
    Kuduk SD; Beshore DC
    Expert Opin Ther Pat; 2012 Dec; 22(12):1385-98. PubMed ID: 23092292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs).
    Kuduk SD; Beshore DC
    Curr Top Med Chem; 2014; 14(15):1738-54. PubMed ID: 25176125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats.
    Miyauchi M; Neugebauer NM; Sato T; Ardehali H; Meltzer HY
    J Psychopharmacol; 2017 Dec; 31(12):1588-1604. PubMed ID: 28946779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunities and challenges for the development of M
    Nguyen HTM; van der Westhuizen ET; Langmead CJ; Tobin AB; Sexton PM; Christopoulos A; Valant C
    Br J Pharmacol; 2024 Jul; 181(14):2114-2142. PubMed ID: 36355830
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.